ncRNA basic information
ncRNA ID:
MI0000808
ncRNA Database:
miRBase
ncRNA Name:
miR-326
ncRNA Type:
miRNA
ncRNA Expression:
up-regulated
ncRNA Method:
qRT-PCR
ncRNA Target Gene:
SP1
ncRNA Pathway:
miR-326/SP1 pathway
Evidence (ncRNA-drug):
validated
drug basic information
Drug ID:
DB00515 (APRD00359)
Drug Name:
Cisplatin
Drug Method:
The expression levels of miRNA were determined by Quantitative real-time PCR and those of protein were by Western blot analysis. Luciferase activity assay was used to verify the target genes of miRNAs. MTT assay was used to test the drug-resistant phenotype changes in cancer cells via overregulation of miRNAs. Animal studies was used to test the role of miR-326 .
Drug Response:
sensitive
Cancer basic information
Cancer:
lung adenocarcinoma
Tissue/Cell:
tissue and cell line (A549,A549/CDDP)
Other information
Title:
miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.
Journal:
Tumour Biol
Published:
2016
PubMed ID:
27460077